In Re AstraZeneca Pharmaceuticals LP v. the State of Texas

Court of Appeals of Texas·Decided May 30, 2025·No. 15-25-00088-CV·Published

Opinion

ACCEPTED 15-25-00088-CV FIFTEENTH COURT OF APPEALS AUSTIN, TEXAS 5/30/2025 3:21 PM No. 15-25-00088-CV CHRISTOPHER A. PRINE CLERK FILED IN 15th COURT OF APPEALS IN THE COURT OF APPEALS AUSTIN, TEXAS FOR THE FIFTEENTH JUDICIAL DISTRICT 5/30/2025 3:21:29 PM AUSTIN, TEXAS CHRISTOPHER A. PRINE Clerk

IN RE: ASTRAZENECA PHARMACEUTICALS LP Relator

Original Proceeding from the 71st Judicial District Court in Harrison County, Texas The Honorable Brad Morin, Presiding

UNOPPOSED MOTION FOR EXTENSION OF TIME TO FILE BRIEF FOR REAL PARTIES-IN-INTEREST AND PLAINTIFFS

Samuel F. Baxter Mark Lanier Jennifer L. Truelove Zeke DeRose McKool Smith, P.C. Jonathan Wilkerson 104 East Houston, Suite 300 THE LANIER FIRM Marshall, Texas 75670 10940 W. Sam Houston Pkwy N, Suite 100 (903) 923-9000 Houston, TX 77064 Fax: (903) 923-9099 (800) 723-3216 Fax: (713) 659-2204

Attorneys for Plaintiffs and Real-Parties-in-Interest SCEF, LLC and Lynne Levin-Guzman

4886-1809-5088 Plaintiffs and Real-Parties-in-Interest (collectively, “Plaintiffs”) respectfully

request a 21-day extension to submit their responsive briefing to the mandamus

petition filed by Relator AstraZeneca Pharmaceuticals LP (“AstraZeneca”), making

the response due on June 30, 2025. In support of their motion, Plaintiffs state as

follows:

1. On May 9, AstraZeneca filed a petition for writ of mandamus

challenging a venue-related ruling the District Court issued on

September 1, 2023—21 months ago.

2. The current deadline for Plaintiffs to file their responsive briefing is

June 9, 2025.

3. Fact discovery in this litigation is scheduled to close in the next few

weeks and, between June 3 and June 30, 2025, the parties are scheduled

to take at least 10 fact depositions.

4. Because Plaintiffs’ legal team is stretched to capacity with fact

discovery, Plaintiffs require a three-week extension to prepare their

responsive briefing to the mandamus petition.

5. Plaintiffs have conferred with AstraZeneca, who has consented to the

relief requested herein.

1 4886-1809-5088 6. Plaintiffs respectfully request that the Court extend the deadline for

Plaintiffs to file their responsive briefing to June 30, 2025.

7. No prior requests to extend the briefing deadlines in this matter have

been made.

2 4886-1809-5088 May 30, 2025 Respectfully submitted,

/s/ Sam Baxter /s/ W. Mark Lanier Samuel F. Baxter (co-lead Mark Lanier (co-lead counsel) counsel) WML@LanierLawFirm.com sbaxter@mckoolsmith.com Zeke DeRose Jennifer L. Truelove Zeke.DeRose@LanierLawFirm.com jtruelove@mckoolsmith.com Jonathan Wilkerson MCKOOL SMITH P.C. Jonathan.Wilkerson@LanierLawFirm.com 104 East Houston, Suite 300 THE LANIER FIRM Marshall, Texas 75670 6810 FM 1960 West (903) 923-9000 Houston, Texas 77069 Fax: (903) 923-9099 (800) 723-3216 Fax: (713) 659-2204

ATTORNEYS FOR PLAINTIFF/REAL- PARTY-IN-INTEREST HEALTH SELECTION GROUP, LLC

3 4886-1809-5088 CERTIFICATE OF SERVICE

The undersigned hereby certifies that, concurrently with the filing of this

motion, a true and correct copy of the above and foregoing document has been served

to counsel of record through the Court’s e-filing system.

/s/ Samuel F. Baxter Samuel F. Baxter

CERTIFICATE OF CONFERENCE

The undersigned certifies that Plaintiffs requested AstraZeneca’s consent to

the relief sought herein. Counsel for AstraZeneca indicated that AstraZeneca

consents to Plaintiffs’ request for extension.

/s/ Samuel F. Baxter Samuel F. Baxter

4 4886-1809-5088 Automated Certificate of eService This automated certificate of service was created by the efiling system. The filer served this document via email generated by the efiling system on the date and to the persons listed below. The rules governing certificates of service have not changed. Filers must still provide a certificate of service that complies with all applicable rules.

Envelope ID: 101451598 Filing Code Description: Motion Filing Description: UNOPPOSED MOTION FOR EXTENSION OF TIME TO FILE BRIEF FOR REAL PARTIES-IN-INTEREST AND PLAINTIFFS Status as of 5/30/2025 3:27 PM CST

Case Contacts

Name BarNumber Email TimestampSubmitted Status

Kennon L.Wooten kwooten@scottdoug.com 5/30/2025 3:21:29 PM SENT

Angela Goldberg agoldberg@scottdoug.com 5/30/2025 3:21:29 PM SENT

Jonathan Wilkerson 24050162 jonathan.wilkerson@lanierlawfirm.com 5/30/2025 3:21:29 PM SENT

Melissa Smith 24001351 melissa@gillamsmithlaw.com 5/30/2025 3:21:29 PM SENT

William Peterson 24065901 William.Peterson@morganlewis.com 5/30/2025 3:21:29 PM SENT

Brian McBride 24002554 scott.mcbride@morganlewis.com 5/30/2025 3:21:29 PM SENT

Zeke DeRose 24057421 zeke.derose@lanierlawfirm.com 5/30/2025 3:21:29 PM SENT

Jennifer Truelove 24012906 jtruelove@mckoolsmith.com 5/30/2025 3:21:29 PM SENT

Alex Brown 24026964 alex.brown@lanierlawfirm.com 5/30/2025 3:21:29 PM SENT

Lynne Kurtz-Citrin 24081425 lynne.kurtz-citrin@oag.texas.gov 5/30/2025 3:21:29 PM SENT

Jonathan Bonilla 24073939 Jonathan.Bonilla@oag.texas.gov 5/30/2025 3:21:29 PM SENT

W. Mark Lanier 11934600 jrm@lanierlawfirm.com 5/30/2025 3:21:29 PM SENT

Heidi Rasmussen 24090345 heidi.rasmussen@morganlewis.com 5/30/2025 3:21:29 PM SENT

Ruth Adams radams@scottdoug.com 5/30/2025 3:21:29 PM SENT

Steve McConnico smcconnico@scottdoug.com 5/30/2025 3:21:29 PM SENT

Jordan Kadjar jkadjar@scottdoug.com 5/30/2025 3:21:29 PM SENT

John Dodds john.dodds@morganlewis.com 5/30/2025 3:21:29 PM SENT

Erica Jaffe erica.jaffe@morganlewis.com 5/30/2025 3:21:29 PM SENT

W. Mark Lanier WML@LanierLawFirm.com 5/30/2025 3:21:29 PM SENT

Cynthia Lu cynthia.lu@oag.texas.gov 5/30/2025 3:21:29 PM ERROR

Steven Strauss steven.strauss@morganlewis.com 5/30/2025 3:21:29 PM SENT

Free access — add to your briefcase to read the full text and ask questions with AI

In Re AstraZeneca Pharmaceuticals LP v. the State of Texas, (Tex. Ct. App. 2025).

In Re AstraZeneca Pharmaceuticals LP v. the State of Texas (In Re AstraZeneca Pharmaceuticals LP v. the State of Texas) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.